Novartis Consumer Health recalls Excedrin Migraine (Acetaminophen 250 mg, Aspirin (NSAID) 250 mg and Caffeine 65 mg), a) 2-count tablets packaged in pouc
Recalled August 14, 2013 · FDA recall D-844-2013 · Novartis Consumer Health
Hazard
Defective container: products are packaged in pouches which may not have been fully sealed · FDA Class II
Units
10,624,000 pouches
Sold at
Nationwide, Puerto Rico, Brazil and Panama
Description
Defective container: products are packaged in pouches which may not have been fully sealed
Product
Excedrin Migraine (Acetaminophen 250 mg, Aspirin (NSAID) 250 mg and Caffeine 65 mg), a) 2-count tablets packaged in pouches, Distributed by Novartis Consumer Health, Inc., Parsippany, NJ, NDC 0067 203 702 Foreign packaging: b) Excedrin Migrana (Acetaminophen 250 mg, Aspirin 250 mg and 65 mg Caffeine) 2-ct pouches. The foreign packaging do not have NDC numbers
Manufacturer(s)
Novartis Consumer Health
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →